e-Article
Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam
Document Type
Article
Author
Source
In: Journal of Clinical Pharmacology . (Journal of Clinical Pharmacology, February 2024, 64(2):155-163)
Subject
Language
English
ISSN
15524604
00912700
00912700